Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold
Author(s): David Power Added: 10 months ago
Outcomes investigating the Absorb bioresorbable vascular scaffold (BVS) in patients undergoing percutaneous coronary intervention showed more adverse ischaemic events through 5 years compared with cobalt-chromium everolimus-eluting stents. However, the period of excess risk ended at 3 years.In this short interview, Dr David Power (Mount Sinai Hospital, New York, US) discusses the final report… View more

Intervention

Prevention & Chronic Conditions
LINC 25: The PATCH Study
Author(s): Sean Lyden Added: 10 months ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more

Intervention

Vascular Disease and Surgery
EHRA 24: The Style-AF Study
Author(s): Roland R Tilz Added: 1 year ago
EHRA 24 - We are joined onsite by Dr Roland Tilz (University Heart Center, DE) to discuss the findings of the Style-AF study (NCT05563142).This prospective, randomized, controlled study aims to compare the safety and efficacy of the Perclose ProStyle suture-medicated closure device to manual compression for the treatment of hemostasis after single-shot-device pulmonary vein isolation (PVI). 125… View more

Vascular Disease and Surgery

Electrophysiology & Arrhythmia
ESC HF 25: The FIVE-STAR Trial
Author(s): Added: 6 months ago
ESC HF 25 - FIVE-STAR primary outcome is neutral, though finerenone was shown to significantly reduce UACR rates with a 29% greater reduction compared to placebo.We are joined by Dr Atsushi Tanaka (Saga University, Saga, JP) to discuss the findings from FIVE-STAR, a randomized trial investigating the effects of finerenone on vascular stiffness and cardiorenal biomarkers in patients with type 2… View more

Cardiovascular Renal Metabolic
CRT 24: The ABSORB Trial
Author(s): David Power Added: 1 year ago
CRT 24 - We are joined in this short virtual interview by investigator, Dr David Power (Mount Sinai Hospital, US) to discuss the latest findings from the ABSORB trial series, revealed in 2024 at the CRT conference.ABSORB III is a prospective, randomized, single-blind, multicenter trail aiming to support the pre-market approval of the Absorb bioresorbable vascular scaffold (Abbott) for the… View more

Intervention

Vascular Disease and Surgery
Fabrizio D'Abate
Job title: Clinical Vascular Scientist
Dr Fabrizio D'Abate leads the sonography team at the UK Vein Clinic, and is a Clinical Vascular Scientist atSt George's University Hospital in London, UK. He is also Co-Founder of ABCvascular, an e-learning platform in vascular ultrasound. In 2022, Dr D'Abate founded LampoVet, a veterinary telemedicine platform. Dr D'Abate completed his MSc in vascular ultrasound in Florence in 2007, before… View more
image
Job title: Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust
Presenter Prof Ajjan is a Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals. He runs a programme of basic, translational and clinical research studies with… View more
Philip J Devereaux
Research Area(s) / Expertise: Job title: Director of the Division of Cardiology
Dr Philip J Devereaux is the Director of the Division of Cardiology at McMaster University. He is also the Scientific Leader of the Anesthesiology, Perioperative Medicine, and Surgical Research Group at the Population Health Research Institute. Dr. Devereaux is a full Professor and University Scholar in the Departments of Health Research Methods, Evidence, and Impact (HEI) and Medicine at… View more